Obesity-Hypoventilation Syndrome, also known as obesity hypoventilation syndrome, is related to apnea, obstructive sleep and sleep disorder, and has symptoms including obesity, metabolically benign An important gene associated with Obesity-Hypoventilation Syndrome is ADIPOQ (Adiponectin, C1Q And Collagen Domain Containing), and among its related pathways/superpathways are IL-9 Signaling Pathways and Spinal cord injury. The drugs Erythromycin and Acetazolamide have been mentioned in the context of this disorder. Affiliated tissues include heart and lung, and related phenotypes are obesity and hypoventilation